Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Otavio Berwanger and Diogo Moia.
Otavio Berwanger
Connection Strength
0.355
Diogo Moia
  1. Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Diabetes Endocrinol. 2021 09; 9(9):586-594.
    View in: PubMed
    Score: 0.239
  2. Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia. N Engl J Med. 2021 07 29; 385(5):406-415.
    View in: PubMed
    Score: 0.059
  3. Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial. Lancet. 2020 10 03; 396(10256):959-967.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.